Jazz Pharmaceuticals

Vibrant colored closed wooden doors in a row on blue sky and sea background
Biotech

Chimerix had 8 suitors: Why Jazz won out

Chimerix considered the downward market trend for biopharma and a general volatility tied to escalating global tensions when assessing Jazz's offer.
Gabrielle Masson Mar 21, 2025 5:17pm
jazz musicians band music saxophone

Jazz hands Chimerix $935M to buy near-approval cancer drug

Mar 5, 2025 8:13am
Parachute over ocean with sunset behind

FDA's principal deputy to depart agency—Chutes & Ladders

Dec 20, 2024 8:30am
Gut stomach

ESMO: Jazz HER2 bispecific posts 59% survival at 30 months

Sep 16, 2024 3:00am
Graphic showing arrows missing the bullseye on a target

Jazz's ph. 2 essential tremor test misses endpoint

Jun 20, 2024 9:30am
Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am